| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...745475L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0045475 |
| P932 | PMC publication ID | 3445522 |
| P698 | PubMed publication ID | 23029035 |
| P5875 | ResearchGate publication ID | 231815379 |
| P50 | author | Christine Decaestecker | Q47015078 |
| P2093 | author name string | Isabelle Salmon | |
| Marie Le Mercier | |||
| Sandrine Rorive | |||
| Nancy De Nève | |||
| Christine Decaestecker | |||
| Anne-Laure Trepant | |||
| Calliope Maris | |||
| Xavier Moles Lopez | |||
| Delfyne Hastir | |||
| P2860 | cites work | Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 |
| The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. | Q54643114 | ||
| IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas | Q43276389 | ||
| Genetic pathways to glioblastoma: a population-based study | Q44673208 | ||
| Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. | Q45918451 | ||
| Gene expression profiling of gliomas strongly predicts survival | Q46043661 | ||
| Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis | Q46057927 | ||
| Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. | Q47999142 | ||
| TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas | Q48096115 | ||
| A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme | Q48260047 | ||
| New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile. | Q48264944 | ||
| Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression | Q48266469 | ||
| Molecular markers of prognosis in astrocytic tumors | Q48514271 | ||
| Identification of clinically useful cancer prognostic factors: what are we missing? | Q52979961 | ||
| IDH1 and IDH2 mutations in gliomas | Q24648948 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
| Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma | Q28290466 | ||
| Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides | Q28731283 | ||
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
| Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience | Q30483391 | ||
| Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration | Q30514241 | ||
| Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations | Q30885944 | ||
| Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance | Q34105339 | ||
| p53 mutation and epidermal growth factor receptor overexpression in glioblastoma | Q34657607 | ||
| Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring | Q36048767 | ||
| Multitissue array review: a chronological description of tissue array techniques, applications and procedures | Q36510355 | ||
| Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. | Q37345320 | ||
| Diagnostic and prognostic markers in gliomas | Q37577244 | ||
| Molecular diagnostics of gliomas: state of the art. | Q37780495 | ||
| Molecular subclassification of diffuse gliomas: seeing order in the chaos | Q37858944 | ||
| Molecular Diagnostics of Gliomas | Q37869917 | ||
| Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy | Q38447589 | ||
| The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. | Q38475723 | ||
| IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas | Q42164790 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e45475 | |
| P577 | publication date | 2012-09-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A simplified approach for the molecular classification of glioblastomas | |
| P478 | volume | 7 |
| Q48915612 | A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India |
| Q35758016 | Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis |
| Q30445696 | An automated blur detection method for histological whole slide imaging |
| Q38528700 | Applicable advances in the molecular pathology of glioblastoma |
| Q38813184 | AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models |
| Q40382294 | Association between RAD 51 rs1801320 and susceptibility to glioblastoma |
| Q38504172 | Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification |
| Q30867941 | CSNK1A1 and Gli2 as Novel Targets Identified Through an Integrative Analysis of Gene Expression Data, Protein-Protein Interaction and Pathways Networks in Glioblastoma Tumors: Can These Two Be Antagonistic Proteins? |
| Q43149195 | Clinical neuropathology practice guide 1-2013: molecular subtyping of glioblastoma: ready for clinical use? |
| Q33786677 | Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity. |
| Q38784169 | Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers |
| Q38098098 | Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma |
| Q38214808 | Galectins and neovascularization in central nervous system tumors |
| Q41898874 | Glioma cell proliferation controlled by ERK activity-dependent surface expression of PDGFRA |
| Q30375102 | IGF-IR: a new prognostic biomarker for human glioblastoma |
| Q39168899 | Immune and viral therapies for malignant primary brain tumors |
| Q36492682 | Lower MGMT expression predicts better prognosis in proneural-like glioblastoma |
| Q47929342 | Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers |
| Q39007403 | Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. |
| Q38707021 | PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma |
| Q34535041 | PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment. |
| Q37619702 | PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals |
| Q38237337 | Predictive biomarkers investigated in glioblastoma. |
| Q55513456 | Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles. |
| Q39475779 | Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence. |
| Q30394840 | Registration of whole immunohistochemical slide images: an efficient way to characterize biomarker colocalization |
| Q92954846 | Role of Klotho Protein in Tumor Genesis, Cancer Progression, and Prognosis in Patients with High-Grade Glioma |
| Q34783220 | Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach. |
| Q36348529 | Subtyping of gliomas of various WHO grades by the application of immunohistochemistry. |
| Q37699420 | Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma |
| Q39027058 | The failure in the stabilization of glioblastoma-derived cell lines: spontaneous in vitro senescence as the main culprit |
| Q35114090 | The future of high-grade glioma: Where we are and where are we going |
| Q33566723 | The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets |
| Q90101140 | Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes |
Search more.